Monitor Your Product. Manage Your Brand.
Counterfeit and grey market products pose tremendous risks, both to consumer safety and to your business’ bottom line. The 6th Anti-Counterfeiting for Pharmaceuticals Summit takes a comprehensive approach to understand the latest regulations for the DSCSA to remain compliant and uphold quality through brand protections plans, anti-counterfeiting strategies, and effective partnerships.
Global Security Associate Director
Director, Global Brand Protection
Global Serialisation Champion and EMEA/CIS/APAC Product Security Leader
President and Owner
Drug Development Resources
Director, Product Security & Supply Chain Risk
Center for Safe Internet Pharmacies
Global Director of Security
Senior Director, Global Risk Management
Otsuka Pharmaceutical Development & Commercialization, Inc.
Serialisation Project Architect
Former Director, Global Conveyance Security
Brand Technologies Manager, Global Product Security
Senior Director, Global Security and Resilience
Alexion Pharmaceuticals, Inc.
Strategic Services Manager
Strategic Account Manager
Key Highlights for 2017 include:
Enhancing Your Outreach of Anti-Counterfeiting Resource Deployment and Allocation
Monitoring a Tailored Global Watch Service - Establishing Proactive Measures to Prevent Global IP Infringement and Track the Sale of Counterfeit Goods
Managing an Effective Anti-Counterfeiting Program - Understanding your Counterfeit Market Landscape and Monitoring Sophisticated Counterfeiters Who Threaten Enforcement Efforts
Raising Awareness and Wellness - Increasing Education for Patient Safety on the Dangers of Counterfeit Medicines
Preventing Diverted Drugs from Entering the Marketplace through Weaknesses in Your Drug Distribution Chain
Measure the Effectiveness of A Good Quality System through Frequent External Audits - Assuring that Products and Processes Conform to Specifications with your Suppliers and Outsourcing Operations
Building Your Brand Protection Strategy - Aligning and Supporting Commercial Strategies To Take Legal Action Against Infringers
Anti-Counterfeiting Authentication Technology Roundtables - Defining the Best Barcoding Technology for your Organization: Understanding its Impact as Part of Your Anti-Counterfeiting Strategy, The Cloud and RFID: Making Seamless Deployment, Nanoparticle-Containing Ink to Combat Counterfeiting Cost Effectively
Intellectual Property Crime through Effective Partnerships with the FBI and U.S. Government Agencies
Conducting Internal Inspections with your QA Unit to Ensure Integrity of Your Brand and Improve Anti-Counterfeiting Operations
Did you know?
Each year, approximately 1 million people around the world die from counterfeit drugs, which account for 30 percent of global drug sales.
2015 survey by Crown Records Management: nearly two-thirds of pharma companies have suffered serious data breaches while a quarter have been hacked. This comes as little surprise as the intellectual property (IP) relating to the drug formulation process is a global business that cost $75 billion in 2010, according to estimates made by the National Association of Boards of Pharmacy.
A 2015 Ponemon global study on the Cost of Cyber Crime revealed that the pharmaceutical sector had one of the highest rate of loss of customers post data breach, as well as a higher data breach cost.